摘要
细胞周期蛋白依赖性激酶 (CDK) 包括约 20 种丝氨酸/苏氨酸激酶家族,其催化活性需要称为细胞周期蛋白的调节亚基;这些酶在细胞周期和转录中发挥多种作用。 PCTAIRE 激酶 (PCTK) 是 CDK 亚家族,其特征在于共有 PSTAIRE 基序中的丝氨酸至半胱氨酸突变,参与与细胞周期蛋白的结合。该类的一个成员是 PCTK3,它有两个同种型(a 和 b),也称为 CDK18。在被细胞周期蛋白 A2 激活或被 PKA 磷酸化 Ser12 后,PCTK3 可以执行多种功能。在这些功能中,我们可以强调以下内容:膜运输中货物运输的调节、p53 响应基因、基因组完整性的调节。根据不同的研究,PCTK3功能障碍与多种疾病有关,如代谢性疾病、脑缺血、抑郁症、癌症、神经系统疾病和阿尔茨海默病等。尽管该蛋白质参与了不同的生物学事件,但我们可以说 PCTK3 受到的关注远低于其他 CDK。关于其他 CDK 的已发表文章数以千计,与 PCTK3 相关的文章不足两百篇。本综述的主要目的是介绍有关该蛋白质的选定已发表研究。与其他 CDK 相比,我们的重点是 PCTK3 的特殊性。在这里,我们概述了 PCTK3 的生物学功能,并探索其作为药物设计靶点的潜力。
关键词: CDK18、PCTAIRE 3、DNA 复制应激、转录、癌症、阿尔茨海默病、PCTK3。
Current Medicinal Chemistry
Title:Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells
Volume: 28 Issue: 33
关键词: CDK18、PCTAIRE 3、DNA 复制应激、转录、癌症、阿尔茨海默病、PCTK3。
摘要: Cyclin-dependent kinases (CDKs) comprise a family of about 20 serine/threonine kinases whose catalytic activity requires a regulatory subunit known as cyclin; these enzymes play several roles in the cell cycle and transcription. PCTAIRE kinases (PCTKs) are a CDK subfamily, characterized by serine to cysteine mutation in the consensus PSTAIRE motif, involved in binding to the cyclin. One member of this class is PCTK3, which has two isoforms (a and b) and is also known as CDK18. After being activated by cyclin A2 or phosphorylation at Ser12 by PKA, PCTK3 can perform several functions. Among these functions, we may highlight the following: modulation of cargo transport in membrane traffic, p53-responsive gene, regulation of genome integrity. According to different studies, PCTK3 dysfunction is related to a wide range of diseases, such as metabolic diseases, cerebral ischemia, depression, cancer, neurological disorders, and Alzheimer's disease. Although this protein participates in different biological events, we may say that PCTK3 has received far less attention than other CDKs. There are thousands of published articles about other CDKs and less than two hundred articles related to PCTK3. The main objective of this review is to present the selected published studies about this protein. Our focus is on PCTK3 particularities compared to other CDKs. Here we give an overview of the biological functions of PCTK3 and explore its potential as a target for drug design.
Export Options
About this article
Cite this article as:
Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells, Current Medicinal Chemistry 2021; 28 (33) . https://dx.doi.org/10.2174/0929867328666210329122147
DOI https://dx.doi.org/10.2174/0929867328666210329122147 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Kringle Structures and Antiangiogenesis
Current Medicinal Chemistry - Anti-Cancer Agents Oral Mucosal Immunization: Recent Advancement and Future Prospects
Current Immunology Reviews (Discontinued) Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions
Current Topics in Medicinal Chemistry Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges
Current Drug Targets Indolealkylamines from Toad Vertebrates and Sea Invertebrates - Their Identification and Potential Activities on the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Disposition of Flavonoids Impacts their Efficacy and Safety
Current Drug Metabolism Subject Index To Volume 2
Current Cardiology Reviews Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Reviews on Recent Clinical Trials Development and Characterization of Amphotericin B Loaded Solid Lipid Nanoparticles Against Experimental Visceral Leishmaniasis
Pharmaceutical Nanotechnology Risk Factors of Recurrent Ischemic Events after Acute Noncardiogenic Ischemic Stroke
Current Pharmaceutical Design X-ray Crystallography and Computational Docking for the Detection and Development of Protein–Ligand Interactions
Current Medicinal Chemistry RAAS Inhibition and Cardiorenal Syndrome
Current Hypertension Reviews Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
Current Drug Targets Anthracyclines Still Prove Effective in Anticancer Therapy
Mini-Reviews in Medicinal Chemistry Carbon Nanotube: A Versatile Carrier for Various Biomedical Applications
Drug Delivery Letters Advances in Drug Safety
Current Pharmaceutical Design Targeting Glycosylation Aberrations to Improve the Efficiency of Cancer Phototherapy
Current Cancer Drug Targets Laser Treatment for Diabetic Macular Edema in the 21<sup>st</sup> Century
Current Diabetes Reviews Expression and Role of the Calcium-Sensing Receptor in the Blood Vessel Wall
Current Pharmaceutical Biotechnology Recent Progress in Research on Ribosome Inactivating Proteins
Current Protein & Peptide Science